Takeda Pharmaceutical Company (NYSE:TAK) Q3 2026 Earnings call January 29, 2026 05:30 AM ET Company ParticipantsAndrew Plump - President of Research & DevelopmentChristophe Weber - CEOChristopher O'Reilly - Head of Investor RelationsJulie Kim - CEO-electMilano Furuta - CFONone - Company RepresentativeConference Call ParticipantsHidemaru Yamaguchi - AnalystHiroyuki Matsubara - AnalystMike Nedelcovych - AnalystSeiji Wakao - AnalystShinichiro Muraoka - AnalystSteve Barker - AnalystTony Ren - AnalystChristopher ...

Takeda Pharmaceutical Company (NYSE:TAK) Q3 2026 Earnings call January 29, 2026 05:30 AM ET Speaker2Thank you for taking time out of a very busy schedule to join us for the earnings announcement for the third quarter, FY 25 by Takeda. I'm the MC, O'Reilly, from IR. I would like to explain the language setting first. Please find the button for the language selection at the bottom of your window for the Zoom screen. If you wish to listen in Japanese, please select Japanese. If you wish to listen in English, p ...